Cargando…
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset
Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase (TPMT) is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a pharmacogenetic guideline. The PanCareLIFE cross-se...
Ejemplares similares
-
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE Study
por: Clemens, Eva, et al.
Publicado: (2019) -
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study
por: Meijer, A. J. M., et al.
Publicado: (2021) -
Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol
por: van der Kooi, Anne-Lotte L. F., et al.
Publicado: (2018) -
Health-Related Quality of Life in European Childhood Cancer Survivors: Protocol for a Study Within PanCareLIFE
por: Calaminus, Gabriele, et al.
Publicado: (2021) -
Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE)
por: van den Berg, Marleen, et al.
Publicado: (2018)